Todd Lubar Shares The Secrets Of His Success

Success in business can take many forms. For Syracuse University graduate, success has taken him places he did not see before. His own life and career has been about seeing and finding opportunities in life. In the process, he’s been able to carve out a life for himself and a career that makes him feel an enormous sense of pride. Todd Lubar majored in speech communications as an undergraduate. This has helped give him the tools he needs to create a career that has helped him rise fast in his chosen field. Todd Lubar has always been a highly driven person. From the very first, he was able to see things and help motivate others to do the same in life. After graduating from college, he decided that the world of business would be his to make his own. In the years since that time, he’s seen his career really take off. From his very first job to his very latest, he’s shown that it is possible to create something in life that is lasting and durable.

Accomplishing Goals

According to Yelp, the cornerstone of his life and his career has been all about accomplishing goals. It’s also been about helping others do the same. Todd has seen as his career first began in Crestar Mortage Corporation. During his four years at the company, he was really able to make a difference. This passion led him to explore other work in the field. He knew that he could help others find the ideal means of financing their dreams. In doing so, he also realized that he had a talent for management and for the field of real estate financing. He was quickly able to rise to the top at his next job at Legacy Financial group. Located in the booming city of Arlington, Texas, this company fully let him explore the field and demonstrate his talents directly. It was here that he was able to push people to new heights. Under his leadership at this company, the company did even more business. His work here has proven to an inspiration for others as well. Check out Instagram for details.

Click here: http://www.toddlubar.com/

Eric Leftkofsky Co-Founded Tempus To Aid Cancer Patient Treatments

Eric Lefkofsky Co-founded the company Tempus with Brad Keywell and he currently operates as the company’s CEO. The technology behind Tempus is being used to compile large amounts of molecular and genomic data into a single database that can be used by doctors to create more precise treatments for cancer patients. Eric is well-known in the business industry as a successful entrepreneur today, having started several of his own companies before Tempus. The majority of people know him from his majority successful Groupon platform, which offers coupons to customers around the world for better deals on everyday things.

Advancements are coming to the fields of healthcare and technology on a regular basis, but there are still many things that are under par that need some serious focus. This was the reason behind Eric’s desire to start up Tempus for cancer treatments. Eric saw cancers disastrous effects up close in his personal life and he noticed the lack of proper data organization and patient dedicated treatments. Eric has stated that data is one of the biggest problems currently facing the medical world. Eric Lefkofsky has been working on structuring data for more than 2 decades, so he knew there was technology available that would make accumulating medical data possible while simultaneously organizing it and bringing it all together.

With the latest rounds of funding over, Tempus has had more than 130 million dollars raised in funding since first starting up in 2015. Eric has said he is willing to personally invest more than 100 million into Tempus to make sure the company can complete its goal. Since Tempus already has the technology it needs to structure and compile data, Eric is working on building a data set. Once this is completed, the end result will be more precise patient information for doctors to use in their cancer treatments for patients around the globe. In the future, Eric believes Tempus will focus on more than just cancer data, but data from many other diseases as well.

To know more click: here.